Forward P/S Multiple: Align Technology (ALGN)

Align Technology, Inc. (ALGN) leads in digital orthodontics by implementing AI-driven planning and advanced 3D scanning. The company's environmental development vector is based on reducing plastic and transitioning factories to green energy. Logistics and cloud data storage have been outsourced to external partners. This forecast P/S chart for Align Technology, Inc. (ALGN) demonstrates the market valuation relative to future sales, where the 1.60 level reflects the current magnitude of this multiple.

aligntech.com - ALGN Market Cap to Projected Revenue (period 07/04/2022 - 11/13/2026)

Summary analytical data breakdowns for Align Corp (ALGN)

- market price and analyst price targets:

Price Chart Align Technology|ALGN - Consensus Target

- company stock exchange capitalization indicators:

Market Capitalization Align Corp|ALGN - Total Enterprise Value

- issuer book value statistics:

Book Value per Share Align Technology|ALGN - Accounting Capitalization|Market Capitalization to Book Value Ratio aligntech.com|ALGN - Company Total Asset Base

- debt and liquidity data:

- financial results and valuation multiples details:

ALGN - Company Net Income|Expected Profit Align Technology, Inc.|ALGN - Market Cap to Net Income Ratio|Projected Price to Earnings Align Technology Inc|ALGN - PEG Multiple|EV/EBITDA Multiple Align Corp|ALGN - Operating income before deduction of amortization|Earnings per share for the last twelve months Align Technology|ALGN - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months aligntech.com|ALGN - Net earnings per share growth this year|Earnings growth forecast for next year Align Technology, Inc.

- sales and revenue indicators:

ALGN - Company Total Revenue|Company Projected Revenue Align Technology|ALGN - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple Align Corp

Fundamental company analysis:ALGN (Align Technology)

Align Technology, Inc. (ALGN) dominates global orthodontics, replacing traditional braces with high-margin 3D technologies and aligners. By analyzing the forward price-to-sales ratio, an investor assesses market capitalization relative to projected sales, which allows for the verification of expansion rates within the teen segment. The stability of this metric confirms the fundamental resilience of the business, helping to filter out short-term volatility when determining the asset's long-term investment potential.

Who Align Technology, Inc. competes with

Price-to-Projected Revenue Ratio Boston Scientific Corporation BSX|EW - Forward Price-to-Revenue Multiple|ResMed Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Insulet Inc.|ZBH: Forward P/S Multiple|Market Cap to Projected Revenue COO|GMED (Globus Medical) - Forward P/S Multiple|TransMedics Group Inc (TMDX) - Market Cap to Expected Sales Ratio|Forward P/S Multiple ATEC|Forward Price-to-Revenue Multiple Artivion Corp AORT|Forward P/S Multiple ENOV (Enovis Corporation)|Forward P/S Multiple integralife.com IART|ESTA - Price-to-Projected Revenue Ratio|BBNX: Price-to-Projected Revenue Ratio|IRMD (Iradimed) - Forward Price-to-Revenue Multiple|Embecta Health - Forward Price to Sales|TNDM (Tandem Diabetes Care) - Forward P/S Multiple|Market Cap to Future Revenue Ratio axogeninc.com AXGN|Price-to-Projected Revenue Ratio SI-BONE (SIBN)|Orthofix Medical (OFIX) - Projected Price to Revenue|Bioventus Corp - Forward Price-to-Revenue Multiple|Forward P/S Multiple OrthoPediatrics Corp KIDS|Treace Medical Concepts - Forward P/S Multiple|Market Cap to Expected Sales Ratio blade.com SRTA|Carlsmed (CARL) - Price-to-Projected Revenue Ratio|Future Price to Revenue RXST (RxSight Inc)|Price-to-Projected Revenue Ratio ClearPoint Neuro Inc.|Forward Price-to-Revenue Multiple Stereotaxis Corporation (STXS)|Forward P/S Multiple STIM|SGHT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Projected Revenue|NSPR: Forward Price-to-Revenue Multiple|Jin Medical International - Price to Expected Revenue Ratio|VANI: Forward P/S Multiple|Xtant Medical (XTNT) - Forward P/S Multiple|Price-to-Projected Revenue Ratio NeuroOne Medical Technologies Corporation|Price-to-Projected Revenue Ratio MODD|Forward P/S Multiple MYO|Market Cap to Expected Sales Ratio Envoy Medical Inc|Forward P/S Multiple VVOS (Vivos Therapeutics)|Projected Price to Revenue envveno.com|SINT - Price-to-Projected Revenue Ratio|TNON (Tenon Medical Inc.) - Market Cap to Projected Revenue|LFWD (ReWalk Robotics Ltd) - Forward Price-to-Revenue Multiple|Autonomix Medical - Forward Price to Sales|Forward Price-to-Revenue Multiple IVF|BBLG (bonebiologics.com) - Price to Expected Revenue Ratio|Forward P/S Multiple AXNX|BIOL - Market Cap to Future Revenue Ratio|Forward P/S Multiple DYNT (Dynatronics)|FNA - Forward Price-to-Revenue Multiple|INVO Bio - Forward P/S Multiple